Ovid Therapeutics Inc.
USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER
Last updated:
Abstract:
Treatment of non 24 sleep wake disorder using gaboxadol or a pharmaceutically acceptable salt thereof is provided. Pharmaceutical compositions that may be used to improve one or more symptoms of non 24 sleep wake disorder are provided.
Status:
Application
Type:
Utility
Filling date:
17 Dec 2019
Issue date:
18 Jun 2020